未登录
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏Pharmacological Characterization of 1-(5-Chloro-6-(trifluoromethoxy)-1H-benzoimidazol-2-yl)-1H-pyrazole-4-carboxylic Acid (JNJ-42041935), a Potent and Selective Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitor
Barrett, Terrance D.; Palomino, Heather L.; Brondstetter, Theresa I.; Kanelakis, Kimon C.; Wu, Xiaodong; Haug, Peter V.; Yan, Wen; Young, Andrew; Hua, Hong; Hart, Juliet C.; Da-Thao Tran; Venkatesan, Hariharan; Rosen, Mark D.; Peltier, Hillary M.; Sepassi, Kia; Rizzolio, Michele C.; Bembenek, Scott D.; Mirzadegan, Tara; Rabinowitz, Michael H.; Shankley, Nigel P.
分享
收藏Benzimidazole-2-pyrazole HIF Prolyl 4-Hydroxylase Inhibitors as Oral Erythropoietin Secretagogues
Rosen, Mark D.; Venkatesan, Hariharan; Peltier, Hillary M.; Bembenek, Scott D.; Kanelakis, Kimon C.; Zhao, Lucy X.; Leonard, Barry E.; Hocutt, Frances M.; Wu, Xiaodong; Palomino, Heather L.; Brondstetter, Theresa I.; Haugh, Peter V.; Cagnon, Laurence; Yan, Wen; Liotta, Lisa A.; Young, Andrew; Mirzadegan, Tara; Shankley, Nigel P.; Barrett, Terrance D.; Rabinowitz, Michael H.
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏Dynamic activation of cystic fibrosis transmembrane conductance regulator by type 3 and type 4D phosphodiesterase inhibitors
Liu, SS; Veilleux, A; Zhang, L; Young, A; Kwok, E; Laliberté, F; Chung, CT; Tota, MR; Dubé, D; Friesen, RW; Huang, Z
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏